Prime Medicine, Inc. (PRME)
(Delayed Data from NSDQ)
$4.10 USD
0.00 (0.00%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $4.10 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
F Value D Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/8/24 |
---|---|
Current Quarter | -0.43 |
EPS Last Quarter | -0.46 |
Last EPS Surprise | -15.00% |
ABR | 1.36 |
Earnings ESP
|
18.92% |
---|---|
Current Year | -1.75 |
Next Year | -1.42 |
EPS (TTM) | -2.01 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 55.00M | NA | 12.47M | 18.27M |
# of Estimates | 1 | NA | 5 | 2 |
High Estimate | 55.00M | NA | 55.59M | 35.80M |
Low Estimate | 55.00M | NA | 0.59M | 0.74M |
Year ago Sales | 0.00M | 0.00M | NA | 12.47M |
Year over Year Growth Est. | NA | NA | NA | 46.46% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.43 | -0.40 | -1.75 | -1.42 |
# of Estimates | 6 | 6 | 7 | 8 |
Most Recent Consensus | -0.41 | -0.28 | -1.86 | -1.11 |
High Estimate | -0.35 | -0.28 | -1.36 | -1.11 |
Low Estimate | -0.47 | -0.47 | -1.91 | -1.80 |
Year ago EPS | -0.55 | -0.56 | -2.03 | -1.75 |
Year over Year Growth Est. | 21.82% | 28.57% | 13.79% | 18.71% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 1 | 1 | 1 |
Up Last 60 Days | 1 | 2 | 1 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.43 | -0.40 | -1.75 | -1.42 |
7 Days Ago | -0.43 | -0.40 | -1.75 | -1.42 |
30 Days Ago | -0.44 | -0.41 | -1.77 | -1.46 |
60 Days Ago | -0.44 | -0.43 | -1.77 | -1.52 |
90 Days Ago | -0.44 | -0.43 | -1.74 | -1.54 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.35 | -0.37 | -1.36 | -1.15 |
Zacks Consensus Estimate | -0.43 | -0.40 | -1.75 | -1.42 |
Earnings ESP | 18.92% | 7.11% | 22.29% | 19.16% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.46 | -0.44 | -0.56 | -0.55 | NA |
Estimate | -0.40 | -0.45 | -0.48 | -0.45 | NA |
Difference | -0.06 | 0.01 | -0.08 | -0.10 | -0.06 |
Surprise | -15.00% | 2.22% | -16.67% | -22.22% | -12.92% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more